Meanwhile, Zhu et al. found that, in OSCC cells, lncRNA HAS2-AS1 (hyaluronan synthase 2 antisense 1) could promote hypoxia-induced cancer progression via inducing the expression of HAS2 (hyaluronan synthase 2) [41]. This evidence concerns the gene HAS2 and cancer.